Genta, Inc.

The announcement of the early halt of Alnylam Pharmaceuticals Inc. 's Phase III ENDEAVOR clinical trial of interfering RNA (RNAi) drug revusiran in 206 patients with hereditary AATR amyloidosis wit

Partners AbbVie and Roche's Genentech scored an important win for their B-cell lymphoma-2 (BCL-2) inhibitor venetoclax in a Phase II clinical trial that met the study's primary endpoint in hard-to-tre

Two years after Genta Inc. ’s Chapter 7 bankruptcy liquidation, the Securities and Exchange Commission charged the biopharmaceutical company’s former president and chief medical officer Loretta Itr

Despite putting up a fight, Genta has resorted to filing for Chapter 7 bankruptcy with the company's directors resigning with immediate effect. In an 8-K SEC filing dated 2 August, the company said it